NPS PHARMACEUTICALS INC Proceeds from Common Stock Issued
NPS PHARMACEUTICALS INC reported Proceeds from Common Stock Issued of $8.12 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-18.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2015-02-18
- NPS PHARMACEUTICALS INC proceeds from issuance of common stock for the quarter ending 2014-12-31 was $8.12M, a 43.96% decline year-over-year.
- NPS PHARMACEUTICALS INC proceeds from issuance of common stock for the quarter ending 2014-09-30 was $0.00.
- NPS PHARMACEUTICALS INC proceeds from issuance of common stock for the quarter ending 2013-12-31 was $14.49M, a 465.64% increase year-over-year.
- NPS PHARMACEUTICALS INC proceeds from issuance of common stock for the quarter ending 2013-09-30 was $0.00.
- NPS PHARMACEUTICALS INC proceeds from issuance of common stock for fiscal 2014 was $8.12M, a 92.48% decline from fiscal 2013.
- NPS PHARMACEUTICALS INC proceeds from issuance of common stock for fiscal 2013 was $107.94M, a 4114.76% increase from fiscal 2012.
- NPS PHARMACEUTICALS INC proceeds from issuance of common stock for fiscal 2012 was $2.56M, a 97.63% decline from fiscal 2011.
- NPS PHARMACEUTICALS INC proceeds from issuance of common stock for fiscal 2011 was $108.16M, a 10.76% increase from fiscal 2010.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month | Proceeds from Issuance of Common Stock 12 month as first filed |
|---|---|---|---|---|---|
| 2014-12-31 | $8.12M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | $8.12M derived: sum of 2 quarters · filed 2015-02-18 | $8.12M 10-K · filed 2015-02-18 | ||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $0.00 10-Q · filed 2014-11-10 | |||
| 2014-06-30 | $0.00 10-Q · filed 2014-08-06 | ||||
| 2013-12-31 | $14.49M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | $14.49M derived: sum of 2 quarters · filed 2015-02-18 | $107.94M 10-K · filed 2015-02-18 | ||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $93.45M 10-Q · filed 2014-11-10 | |||
| 2013-06-30 | $93.45M 10-Q · filed 2014-08-06 | ||||
| 2012-12-31 | $2.56M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | $2.56M derived: sum of 2 quarters · filed 2015-02-18 | $2.56M 10-K · filed 2015-02-18 | $254.00K 10-K · filed 2013-02-21 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $0.00 10-Q · filed 2013-11-06 | |||
| 2012-06-30 | $0.00 10-Q · filed 2013-08-08 | ||||
| 2011-12-31 | $108.16M 10-K · filed 2014-02-18 | $107.03M 10-K · filed 2012-02-15 | |||
| 2010-12-31 | $97.66M 10-K · filed 2013-02-21 | ||||
| 2009-12-31 | $3.47M 10-K · filed 2012-02-15 |